LONDON: British health officials said the Delta variant of Covid-19 continued its rise in the UK with 36,800 cases entered on Friday, which marked a 17 percent increase in the previous week.
Public Health England (PHE) said that while infection continued to high and increased, there was no appropriate increase in the number of inpatients with Covid-19, indicating that effective vaccination against a very translisting variant was identified in India.
Of the 36,800 cases of Delta variant B1.617.2 during the past week, 45 of the Delta AY.1 sub-line with the mutation of the K417N, which was feared more resistant vaccines – the proportion that remained consistent for the past few weeks.
“The level of the case is still high and up, but encourages that the increase in cases still does not seem to be related to a similar increase in hospitalization and death.
This is proof of continued success from the vaccination program in reducing the incidence of severe illness,” said Dr.
Jenny Harries, Chief Executive of the Agency English health security.
“The best way to keep yourself and the people around you safe is get a vaccine dose as soon as you qualify.
However, while the vaccine offers excellent protection, they don’t completely eliminate risk,” he said.
“When we approach the end of the restriction, it is just as important as we are careful.
Take your free twice weekly test and if you have symptoms, you must order a PCR test immediately and stay at home until you receive your results,” he added.
The latest statistics came as a separate study disclosed on Thursday that nearly 100 percent of people were tested positive for antibodies of 14 days or more after their second covid-19 vaccine dose – from the Pfizer / Bionech or Oxford / AstraZeneca vaccine, managed in India as a covishield.
Imperial College London and Ipsos Mori said their latest antibody supervision reports highlighted the importance of getting the best dose for the best protection against Coronavirus because the limitation of locking continued from next Monday.
More than 90 percent of people over 65 were tested positive for antibodies, increasing to 95 percent in those over 75 with 36 percent aged 18 to 24 years testing positive.
At the time of the report, a quarter of respondents aged 18 to 24 years said they had received one or two Jab compared to 99 percent of those aged over 75.
After a dose of vaccine, the proportion of people tested positive antibodies at 4 to 5 weeks after the first dose And then it starts to decline before going up substantially on those who have the second dose.
“Every vaccine is another brick on our protection wall and I am very happy that the latest data from reacting [Real-time assessment of community transmission assessment] shows almost 100 percent of people tested positively for antibodies after the second dose of their vaccines,” said the UK Health Secretary Javid Sajid.
Minister of Vaccine Nadhim Zahawi added: “Our vaccination program works and greatly weakens the relationship between cases, hospitalization, and death.” When we lift the restrictions next week, I urge anyone who has not been vaccinated to get both Jab to protect yourself and people who are You love.
The vaccine is safe and so far prevents around 8 million infections, more than 46,000 inpatients and around 30,000 deaths.
“The British government said it was on the right track to offer every first dose of vaccine on Monday, when the restrictions on England’s legal locking would end, and also had given two doses to two thirds of all adults.